Home
Scholarly Works
Sofosbuvir-velpatasvir for 12 weeks is safe and...
Conference

Sofosbuvir-velpatasvir for 12 weeks is safe and effective in patients undergoing dialysis

Authors

Pianko S; Borgia S; Dearden J; Lurie Y; Shafran S; Brown A; Hyland R; Lu S; Markova S; Dvory-Sobol H

Volume

34

Pagination

pp. 102-102

Publisher

WILEY

Publication Date

September 1, 2019

Conference proceedings

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

ISSN

0815-9319

Labels

Fields of Research (FoR)

Contact the Experts team